The Covid-19 pandemic has presented the industry with many risks and challenges to the management of clinical trials. For many, the mitigation of these issues has accelerated the implementation of decentralized approaches to monitoring and management of clinical trials.

In this webinar, we will discuss:

  1. What risks and challenges COVID-19 has presented
  2. Ways in which these can be addressed
  3. Rho as a Case study

Featured Speakers

Marina Acosta-Enslen

Associate Director, Clinical Management

Marina is a diversely skilled clinical research professional with 20 years of experience across Phase 1 through 4 studies. Prior to joining Rho, Marina has held positions in the areas of clinical monitoring, site level study coordination, site start-up, and clinical study management. She has extensive experience working on a variety of therapeutic areas, including regional and global HIV, Oncology, Acute Pain and Vaccine clinical trials. Nearly half of her career has been focused in HIV/AIDS research working on NIH and industry funded clinical trials.

Nicholas Poulson

Senior Project Manager

Nick has 8 years of clinical trial experience managing, monitoring, and coordinating Phase 2-4 clinical trials across various therapeutic areas, including pain.  He received his doctorate Degree in Cell Biology with a focus on cell division and the cell cycle from Duke University.  With this experience also comes expertise in managing at home reported assessments via paper diaries and ePRO devices to ensure timely and accurate reporting by subjects.   Additionally, he has a strong understanding of clinical trial management and delivery requirements that has allowed him to successfully lead teams to meet timeline deliverables for various multi-center trials.

Fran Sawyer

Clinical Team Lead

Fran has over 13 years of industry experience including serving as a lead on a Vaccine, Cardiovascular, Pain, COPD, and Osteoarthritis trials. Her other study indications include high risk vascular disease and lowering LDL, atrial fibrillation, asthma, graft versus host, breast cancer, and sickle cell disease. She joined Rho in 2014 and is a seasoned leader with training and mentoring experience. Ms. Sawyer has a strong understanding of clinical trial management and delivery requirements that has allowed her teams to successfully meet data timeline deliverables for various multi-center trials. She is also adept in all aspects of GCPs, regulatory requirements, and site management. Ms. Sawyer earned her BS from North Carolina State University in Raleigh.

Date:  Wednesday, October 7, 2020
Time:  1pm ET / 10am PT
Duration:  1 Hour

Register now for this webinar